Add to My Stocks
$2 $0.1 (5.26%) ZOM stock closing price Sep 25, 2018 (Closing)

The financial analysis of ZOM requires an investor to check the cash flows for ZOMEDICA PHARMA. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about ZOMEDICA PHARMA profits and ZOMEDICA PHARMA debt. ZOMEDICA PHARMA cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. ZOMEDICA PHARMA had cash and cash equivalents of $3.22M at the beginning of the quarter and $4.27M at quarter end for 2018 Q2. ZOM decrease in investments stood at a value of $-0.13M for the latest quarter 2018 Q2.

View and download details of ZOMEDICA PHARMA cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q22017 Q12016 Q4
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow------
Net Increase (Decrease) in Assets Liabilities---0.24M-0.49M--0.35M
Cash From (used in) Discontinued Operations------
Other Adjustments Net1.24M-1.12M--1.48M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.13M-0.01M-0.17M-0.15M-0.15M-0.23M
Acquisition Disposition of Subsidiaires------
Increase (Decrease) in Investments------
Other Cash Inflow (Outflow) from Investment Activities------0.01M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares1.43M1.4M---4.79M
Issuance (Repayment) of Debt Securities---0.01M-0.01M-0.01M-
Increase (Decrease) in Bank & Other Borrowings------
Payment of Dividends & Other Cash Distributions------
Other Cash from (used by) Financing Activities3.97M-6.51M3.21M-0.01M-0.01M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year3.22M3.24M----
Cash & Equivalents at Year End4.27M3.13M3.44M2.64M1.76M3.22M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

While ZOMEDICA PHARMA stock price history provides the price history of a stock, ZOMEDICA PHARMA stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • ZOMEDICA PHARMA had a Net Change in Cash and Cash Equivalents of $- in the latest quarter 2018 Q2. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the ZOMEDICA PHARMA stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: ZOMEDICA PHARMA reported a negative operating cash flow of $-4.44M till 2018 Q2 and has seen a decrease from the previous quarter. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-0.13M for ZOM stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. ZOMEDICA PHARMA earned $5.41M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For ZOMEDICA PHARMA Cash Flow

Quarterly Cash Flow Statements For ZOMEDICA PHARMA Peers

ALLERGY THERAPT cash flow, Durect cash flow, KALVISTA PHARMA cash flow, Lannett Co cash flow